← All medicines
Vaxneuvance suspension for injection in pre-filled syringe
Licence EU/1/21/1591/001-006 · Unknown
- Licence holder
- Merck Sharp & Dohme BV, (all products →)
- Active substances
- Pneumococcal Polysaccharide Serotype 1 Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 3 Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 4 Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 5 Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 6A Conjugated to CRM197, Pneumococcal polysaccharide serotype 7f, Pneumococcal Polysaccharide Serotype 9V Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 14 Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 18C Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 19A Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 19F Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 22F Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 23F Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 33F Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 6B Conjugated to CRM197
- Dosage form
- Suspension for injection in pre-filled syringe
- Route of administration
- Intramuscular use
- ATC code
- J07AL
- First authorised
- 13/12/2021
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.